JSJay Simhan

Jay Simhan

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Jay Simhan has a total of 218 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Multicenter Analysis of Long-Term Outcomes of Artificial Urinary Sphincter Surgery After Urethroplasty

    by Meghan F. Davis, Dmitriy Nikolavsky, Andre G. Cavalcanti, Brian J. Flynn, Reynaldo G. Gomez, Jeff Loh-Doyle, Stuart D. Boyd, Akio Horiguchi, Matthias D. Hofer, Margit Fisch, et al.

    The artificial urinary sphincter (AUS) is the gold standard for male stress urinary incontinence (SUI). There is limited and conflicting evidence examining outcomes in AUS insertion after urethroplasty particularly whether and how urethroplasty techniques affect them. We evaluated complications of AUS insertion after urethroplasty in a multi-institutional cohort. We hypothesize that complications occur at higher rates and vary between transecting and non-transecting urethroplasty. We retrospectively reviewed patients who underwent AUS after urethroplasty at 15 institutions. Demographic and clinical variables were analyzed. Urethroplasties were categorized as transecting or non-transecting. Long-term complications included AUS infection, erosion, and mechanical failure. 178 cases were identified performed by 17 surgeons (range 4-40) from 15 institutions with median follow-up of 33.5 (IQR 46) months). AUS complications requiring explantation, including infection, erosion and mechanical failure following transecting urethroplasty occurred in 56.2% compared to 23.5% following non-transecting urethroplasty (p < 0.001). Transecting urethroplasty technique was correlated with increased risk of device explant both from erosion (p=0.004) and atrophy (p=0.008). Radiation (HR 0.46, 95% CI 0.28-0.76, p=0.002), hypertension (HR 0.44, 95% CI 0.27-0.73, p=0.0008) and patient age (>68) (HR 0.5, 95% CI 0.3-0.81, p=0.004) also correlated to risk of device explantation. Risk of experiencing AUS complications is higher in patient with transecting urethroplasty compared to the non-transecting group. Non-transecting urethroplasty may be advisable if a subsequent need for AUS is anticipated.


  • Open Access

    Contemporary management of radiation-associated posterior urethral stenosis: a narrative review

    by Samuel J. Ivan, Matthew Lee, Jay Simhan

    Background and Objective: Radiation-associated posterior urethral stenosis is a challenging entity to treat due to the complex anatomic location and post-radiation tissue compromise. This narrative review examines available data regarding treatment options for posterior urethral stenosis in the radiated patient population. We highlight recent advancements in surgical technique and offer the authors’ opinion on an effective management approach. Methods: We reviewed English language articles from 2000 to 2025 in the PubMed, Web of Science, and CINAHL databases. Key Content and Findings: It is crucial to assess functional bladder health prior to reconstruction as patients with a history of radiotherapy may demonstrate poor capacity, poor compliance, and/or refractory cystitis. Endoscopic management options are typically pursued first but are associated with high rates of reoperation in this population. A new endoscopic technique involving mucosal incision and reapproximation offers theoretical improvements over traditional incision and dilation. Abdominal and perineal approaches may be effective in refractory cases and recent data describing the use of buccal mucosal grafts in this radiated population is promising. Robot-assisted reconstruction for radiation-associated posterior urethral stenosis is associated with high rates of perineal counter-incision and subsequent reoperation. Conclusions: Management of radiation-associated posterior urethral stenosis remains challenging and is associated with significant rates of revision and de novo incontinence. Emerging techniques, including transurethral incision and transverse mucosal realignment, substitution urethroplasty with buccal mucosal graft, and robot-assisted posterior urethral reconstruction, may improve surgical outcomes but will require confirmatory data.


  • Prior Radiation Therapy is Associated With Increased Risk of Intraoperative Complications in Patients Undergoing Primary Inflatable Penile Prosthesis Placement: Results From a Large Multi-institutional Collaborative

    by Zafardjan Dalimov, Samuel J. Ivan, David W. Barham, Muhammed Hammad, Jake Miller, Robert Andrianne, Arthur L. Burnett, Kelli Gross, Georgios Hatzichristodoulou, James Hotaling, et al.


  • Open Access

    Preface to “Complex Penile Prosthesis Surgery”

    by David W. Barham, Jay Simhan, Martin S. Gross

    Preface to “Complex Penile Prosthesis Surgery”

  • Open Access

    The fragile urethra: what to do next?—a narrative review

    by Aroh Pandit, Chrystal Chang, Jay Simhan

    Background and Objective: Although the artificial urinary sphincter (AUS) has demonstrated successful outcomes in treating male stress urinary incontinence (SUI) for the past five decades, this procedure also carries inherent risks, including recurrent SUI, device malfunction, local tissue compromise, and infection/erosion, all of which may require revision surgery with or without device replacement. Patients that are at the highest risk for such untoward events often possess unhealthy urethral tissue (termed a “fragile urethra”) that is compromised and unable to provide optimal cuff coaptation and continence. Accordingly, there are several techniques to address recalcitrant SUI in the setting of a fragile urethra to afford an improved chance of return to continence. Here, we review characteristics of patients that are at higher risk for an untoward outcome following AUS implantation and further define strategies to promote optimal success with device implantation. The aim of this paper is to review the available literature and describe surgical options for male SUI in patients with known or anticipated urethral tissue compromise. Methods: A thorough literature review was completed by querying PubMed for relevant articles. Search terms included artificial urinary sphincter, failure, recalcitrant, urethral atrophy, fragile urethra, revision, radiation, cystectomy, incontinence, and/or urethroplasty published between 1975 and 2022. Key Content and Findings: Options for management of the fragile urethra include cuff relocation, cuff downsizing, tandem cuff placement, transcorporal cuff placement, pressure regulating balloon exchange with increased or decreased pressure, bulbospongiosus preservation, sub-cuff ventral capsulotomy, urethral wrapping with graft, and in select cases, urinary diversion, or complete device removal with a return to SUI. Proper patient selection is paramount to optimize outcomes. Advantages and disadvantages of each strategy are reviewed. Conclusions: Numerous techniques are viable options for patients with recalcitrant SUI in the setting of a fragile urethra, but high-quality evidence with reproducible outcomes for many of these strategies remain limited. Proper patient selection as well as adequate counseling by experienced implant surgeons may help optimize outcomes. Further multi-institutional investigations with longer term outcomes are needed to improve patient selection and counseling with shared decision-making prior to any intervention.


  • Factors Affecting Implant Length in Primary Inflatable Penile Prosthesis Placement

    by Jake A. Miller, Muhammed Hammad, Eliad Amini, Robert Andrianne, Arthur L. Burnett, Kelli Gross, Martin S. Gross, Georgios Hatzichristodoulou, James Hotaling, Tung-Chin Hsieh, et al.


  • Penoscrotal inflatable penile prosthesis recipients often fully recover from pain at two weeks following placement

    by Alice Xiang, Avery E. Braun, Chrystal Chang, Daniel Swerdloff, Martin S. Gross, Jay Simhan

    The symptoms and duration of pain following inflatable penile prosthesis (IPP) surgery remains poorly understood. We characterize postoperative pain following penoscrotal 3-piece inflatable penile prosthesis placement in patients managed with a standardized pain management protocol. This is a single-center prospective analysis of 96 virginal penoscrotal 3-piece IPP recipients (9/2019 to 9/2021) excluding patients with chronic pain, IPPs performed with alternative approaches or concomitantly with other surgeries and those with infections. Standardized pain questionnaire was performed by phone on post-operative day (POD) 2, 7, 14, and 30. The primary outcome was self-reported pain scores, measured by pain score 0–10 (0 = no pain, 10 = unbearable, “worst pain you have ever felt”) at various locations (incision, penile, scrotal, abdominal) over the first 30 days postoperatively. A majority of pain reported was outside the scrotal area with 67.6% of complaints in the shaft, glans, abdomen and incision. From POD2 to POD30, there was a significant decrease in severe pain from 46.2 to 11.1% (p = 0.05) with an increase in mild pain from 23.1 to 62.4% (p = 0.05). Roughly half of the participants (47.9%, n = 46) reported no pain by POD14. Penoscrotal IPP recipients often fully recover from pain at the two-week period following surgery and those with lingering discomfort predominantly complain of penile shaft and glans pain.


  • Reply by Authors

    by Joshua Sterling, Jay Simhan, Brian J. Flynn, Paul Rusilko, Wagner A. França, Erick A. Ramirez, Javier C. Angulo, Francisco E. Martins, Hiren V. Patel, Margaret Higgins, et al.

  • Open Access

    Multi-Institutional Outcomes of Dorsal Onlay Buccal Mucosal Graft Urethroplasty in Patients With Postprostatectomy, Postradiation Anastomotic Stenosis

    by Joshua Sterling, Jay Simhan, Brian J. Flynn, Paul Rusilko, Wagner A. França, Erick A. Ramirez, Javier C. Angulo, Francisco E. Martins, Hiren V. Patel, Margaret Higgins, et al.

    The treatment of urethral stenosis after a combination of prostatectomy and radiation therapy for prostate cancer is understudied. We evaluate the clinical and patient-related outcomes after dorsal onlay buccal mucosal graft urethroplasty (D-BMGU) in men who underwent prostatectomy and radiation therapy. A multi-institutional, retrospective review of men with vesicourethral anastomotic stenosis or bulbomembranous urethral stricture disease after radical prostatectomy and radiation therapy from 8 institutions between 2013 to 2021 was performed. The primary outcomes were stenosis recurrence and development of de novo stress urinary incontinence. Secondary outcomes were surgical complications, changes in voiding, and patient-reported satisfaction. Forty-five men were treated with D-BMGU for stenosis following prostatectomy and radiation. There was a total of 7 recurrences. Median follow-up in patients without recurrence was 21 months (IQR 12-24). There were no incidents of de novo incontinence, 28 patients were incontinent pre- and postoperatively, and of the 6 patients managed with suprapubic catheter preoperatively, 4 were continent after repair. Following repair, men had significant improvement in postvoid residual, uroflow, International Prostate Symptom Score, and International Prostate Symptom Score quality-of-life domain. Overall satisfaction was +2 or better in 86.6% of men on the Global Response Assessment. D-BMGU is a safe, feasible, and effective technique in patients with urethral stenosis after a combination of prostatectomy and radiation therapy. Although our findings suggest this technique may result in lower rates of de novo urinary incontinence compared to conventional urethral transection and excision techniques, head-to-head comparisons are needed.


  • Does climate impact inflatable penile prosthesis infection (IPP) risk? Assessment of temperature and dew point on IPP infections

    by David W Barham, Nikolaos Pyrgidis, Eliad Amini, Muhammed Hammad, Jake Miller, Robert Andrianne, Arthur L Burnett, Kelli Gross, Georgios Hatzichristodoulou, James Hotaling, et al.

    Background: Variations in climate have been associated with a greater risk of surgical site infections, urinary tract infections, and changes in the skin microbiome; however, limited data exist on the impact of climate on inflatable penile prosthesis (IPP) infections. Aim: We sought to evaluate the impact of climate on the risk of IPP infections in a large international, multicenter cohort. Methods: We performed a multi-institutional, retrospective study of patients undergoing IPP surgery. We then evaluated whether the month or season, during which surgery was performed, affected device infections. Implant infections were defined as infections requiring device explantation. A univariate logistic regression analysis was undertaken. Outcomes: Our primary outcome was implant infection. Results: A total of 5289 patients with a mean age of 62.2 ± 10.8 years received IPP placement. There was a fairly even distribution of implants performed in each season. A total of 103 (1.9%) infections were recorded. There were 32 (31.1%) IPP infections in patients who underwent surgery in the summer, followed by 28 (27.2%) in the winter, 26 (25.2%) in the spring, and 17 (16.5%) in the fall. No statistically significant differences were recorded in terms of season (P = .19) and month (P = .29). The mean daily temperature (P = .43), dew point (P = .43), and humidity (P = .92) at the time of IPP placement was not associated with infection. Clinical Implications: These findings provide reassurance to prosthetic urologists that infection reduction strategies do not need to be tailored to local climate. Strengths and Limitations: Climate data were not directly recorded for each hospital, but rather based on the monthly averages in the city where the surgery was performed. Conclusion: The climate at time of IPP placement and time of year of surgery is not associated with IPP infection risk.